CLINICAL_TRIALS
trial_result
· 2011-06-23
Clinical Trial Update: C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study) [Phase 3]
Summary
A Phase 3 extension study of a C1 esterase inhibitor for hereditary angioedema has completed, with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CSL Behring | Conditions: Hereditary Angioedema | Phase 3 | Status: COMPLETED | Results posted: 2011-06-23